Blog
RSS FeedPosted by Michael Wonder on 24 Feb 2020
Alberta’s switch to biosimilar drugs may pose legal challenges for doctors
24 February 2020 - Prescribing cheaper medications for arthritis, diabetes or Crohn’s disease could be at odds with physicians’ legal requirement ...
Posted by Michael Wonder on 22 Feb 2020
'Heartbreaking' death of cystic fibrosis patient shines light on drug access issues
21 February 2020 - 23-year-old Chantelle Lindsay died Wednesday after she was denied life saving drug. ...
Posted by Michael Wonder on 20 Feb 2020
Canadian regulator considers changes to new drug pricing plan
20 February 2020 - Canada’s drug pricing agency is contemplating significant changes to how it will apply new regulations aimed at ...
Posted by Michael Wonder on 18 Feb 2020
CEADM applauds CADTH's decision to recommend an innovative depression medication for publicly-funded drug plans in Canada
18 February 2020 - Canadians for Equal Access to Depression Medication (CEADM) applauds the CADTH's recent decision recommending that the ...
Posted by Michael Wonder on 18 Feb 2020
Family remains hopeful after request for life-saving drug is denied
16 February 2020 - The past month and a half has been hard on the Lindsay family, as Mark Lindsay ...
Posted by Michael Wonder on 14 Feb 2020
AbbVie's Skyrizi now listed on the Nova Scotia formulary for the treatment of moderate to severe plaque psoriasis
13 February 2020 - Nova Scotia lists Skyrizi on its provincial formulary effective February 06, 2020. ...
Posted by Michael Wonder on 14 Feb 2020
Canada ponders a federal programme for pharmaceuticals
14 February 2020 - The country’s vaunted public health-care system has a big gap. ...
Posted by Michael Wonder on 13 Feb 2020
The grass is the same colour, part II: prescription drug woes on both sides of the US-Canada border
13 February 2020 - Which industrialised nation with a fractured health care system and a divided government is having a high-stakes ...
Posted by Michael Wonder on 12 Feb 2020
Quebec, New Brunswick, Newfoundland, Nova Scotia and Manitoba join Alberta, Saskatchewan, in adding Knight’s Probuphine to their provincial drug plans in the fight against the opioid crisis
11 February 2020 - Probuphine is also listed for reimbursement through the Non-Insured Health Benefit (NIHB) and Veteran Affairs Canada drug ...
Posted by Michael Wonder on 09 Feb 2020
N.S. senior blasts province over blood thinner coverage under pharmacare
6 February 2020 - Province covers warfarin, but it requires closer monitoring than newer, more expensive alternative, apixaban. ...
Posted by Michael Wonder on 09 Feb 2020
Extreme regulations to lower drug prices mean Canada will get fewer new drugs
7 February 2020 - Severe price cuts would clearly discourage pharmaceutical manufacturers from launching new drugs in Canada. ...
Posted by Michael Wonder on 07 Feb 2020
AbbVie's Skyrizi now publicly reimbursed in Ontario, Alberta, Saskatchewan and Quebec for the treatment of moderate to severe plaque psoriasis
6 February 2020 - Skyrizi is the only IL-23 inhibitor to arrive at a positive conclusion with the pCPA and is ...
Posted by Michael Wonder on 05 Feb 2020
Pharma execs argue new Canadian regulations for setting drug prices will hurt the country
4 February 2020 - As Canada gets set to implement new regulations designed to cut prescription drug spending, the pharmaceutical ...
Posted by Michael Wonder on 31 Jan 2020
When a lottery 'wins' sick babies life-saving drugs
30 January 2020 - Eva was diagnosed with spinal muscular atrophy, a motor neuron disease, just a few weeks after ...
Posted by Michael Wonder on 30 Jan 2020
The life-saving medicine she needs is cheap, common and unavailable in Canadian pharmacies
30 January 2020 - Cassidy Armstrong among a fewer than 200 Canadians who must apply for access. ...